Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II - PubMed (original) (raw)
Controlled Clinical Trial
Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II
Fereidoun Azizi et al. Trials. 2009.
Abstract
Background: The Tehran Lipid and Glucose Study (TLGS) is a long term integrated community-based program for prevention of non-communicable disorders (NCD) by development of a healthy lifestyle and reduction of NCD risk factors. The study begun in 1999, is ongoing, to be continued for at least 20 years. A primary survey was done to collect baseline data in 15005 individuals, over 3 years of age, selected from cohorts of three medical heath centers. A questionnaire for past medical history and data was completed during interviews; blood pressure, pulse rate, and anthropometrical measurements and a limited physical examination were performed and lipid profiles, fasting blood sugar and 2-hours-postload-glucose challenge were measured. A DNA bank was also collected. For those subjects aged over 30 years, Rose questionnaire was completed and an electrocardiogram was taken. Data collected were directly stored in computers as database software- computer assisted system. The aim of this study is to evaluate the feasibility and effectiveness of lifestyle modification in preventing or postponing the development of NCD risk factors and outcomes in the TLGS population.
Design and methods: In phase II of the TLGS, lifestyle interventions were implemented in 5630 people and 9375 individuals served as controls. Primary, secondary and tertiary interventions were designed based on specific target groups including schoolchildren, housewives, and high-risk persons. Officials of various sectors such as health, education, municipality, police, media, traders and community leaders were actively engaged as decision makers and collaborators. Interventional strategies were based on lifestyle modifications in diet, smoking and physical activity through face-to-face education, leaflets & brochures, school program alterations, training volunteers as health team and treating patients with NCD risk factors. Collection of demographic, clinical and laboratory data will be repeated every 3 years to assess the effects of different interventions in the intervention group as compared to control group.
Conclusion: This controlled community intervention will test the possibility of preventing or delaying the onset of non-communicable risk factors and disorders in a population in nutrition transition.
Trial registration: ISRCTN52588395.
Figures
Figure 1
The minimum and maximum distances between intervention and control groups are 1.5 and 5 kilometers, respectively. Map of areas of control (C) and intervention (I) groups.
Similar articles
- Isfahan Healthy Heart Programme: a comprehensive integrated community-based programme for cardiovascular disease prevention and control. Design, methods and initial experience.
Sarraf-Zadegan N, Sadri G, Malek Afzali H, Baghaei M, Mohammadi Fard N, Shahrokhi S, Tolooie H, Poormoghaddas M, Sadeghi M, Tavassoli A, Rafiei M, Kelishadi R, Rabiei K, Bashardoost N, Boshtam M, Asgary S, Naderi G, Changiz T, Yousefie A. Sarraf-Zadegan N, et al. Acta Cardiol. 2003 Aug;58(4):309-20. doi: 10.2143/AC.58.4.2005288. Acta Cardiol. 2003. PMID: 12948036 - Nutritional knowledge, attitude and practice of Tehranian adults and their relation to serum lipid and lipoproteins: Tehran lipid and glucose study.
Mirmiran P, Mohammadi-Nasrabadi F, Omidvar N, Hosseini-Esfahani F, Hamayeli-Mehrabani H, Mehrabi Y, Azizi F. Mirmiran P, et al. Ann Nutr Metab. 2010;56(3):233-40. doi: 10.1159/000288313. Epub 2010 Mar 30. Ann Nutr Metab. 2010. PMID: 20375546 - Effect of nutrition intervention on non-communicable disease risk factors among Tehranian adults: Tehran Lipid and Glucose Study.
Mirmiran P, Ramezankhani A, Hekmatdoost A, Azizi F. Mirmiran P, et al. Ann Nutr Metab. 2008;52(2):91-5. doi: 10.1159/000121364. Epub 2008 Mar 18. Ann Nutr Metab. 2008. PMID: 18349527 - Contributions and Implications of the Tehran Lipid and Glucose Study.
Azizi F, Takyar M, Zadeh-Vakili A. Azizi F, et al. Int J Endocrinol Metab. 2018 Oct 31;16(4 Suppl):e84792. doi: 10.5812/ijem.84792. eCollection 2018 Oct. Int J Endocrinol Metab. 2018. PMID: 30584448 Free PMC article. Review. - Personalized prevention approach with use of a web-based cardiovascular risk assessment with tailored lifestyle follow-up in primary care practice--a pilot study.
van den Brekel-Dijkstra K, Rengers AH, Niessen MA, de Wit NJ, Kraaijenhagen RA. van den Brekel-Dijkstra K, et al. Eur J Prev Cardiol. 2016 Mar;23(5):544-51. doi: 10.1177/2047487315591441. Epub 2015 Jun 16. Eur J Prev Cardiol. 2016. PMID: 26080811 Review.
Cited by
- Body composition analysis in women with polycystic ovary syndrome: a cross-sectional study from the Tehran Lipid and Glucose Study (TLGS).
Zakeri A, Ebadinejad A, Rahmati M, Momenan AA, Niroomand M, Valizadeh M, Azizi F, Tehrani FR, Hosseinpanah F. Zakeri A, et al. BMC Endocr Disord. 2024 Nov 19;24(1):251. doi: 10.1186/s12902-024-01783-2. BMC Endocr Disord. 2024. PMID: 39558339 - Glycemic index and glycemic load of brief sugary sweets: randomized controlled trials of eight Thai desserts.
Namjud N, Senaprom S, Ondee T, Bumrungpert A, Heath J, Pongpirul K. Namjud N, et al. Front Nutr. 2024 Oct 30;11:1452602. doi: 10.3389/fnut.2024.1452602. eCollection 2024. Front Nutr. 2024. PMID: 39539376 Free PMC article. - Association between body mass index trajectories and type 2 diabetes incidence over an 18-year follow-up in the Tehran Lipid and Glucose Study.
Hassanloo N, Mehran L, Amouzegar A, Abdi H, Masoumi S, Azizi F, Maroufi SP. Hassanloo N, et al. Sci Rep. 2024 Nov 11;14(1):27615. doi: 10.1038/s41598-024-75179-6. Sci Rep. 2024. PMID: 39528497 Free PMC article. - Blood pressure status, quality of life, and emotional states in adults with different disease awareness and treatment adherence.
Niknam M, Zolfagharypoor A, Cheraghi L, Izadi N, Azizi F, Amiri P. Niknam M, et al. Sci Rep. 2024 Nov 4;14(1):26699. doi: 10.1038/s41598-024-77857-x. Sci Rep. 2024. PMID: 39496726 Free PMC article. - The trend of correlation changes of macronutrient intakes among different familial pairs: a prospective study among participants of Tehran Lipid and Glucose Study.
Teymoori F, Saber N, Akbarzadeh M, Farhadnejad H, Mokhtari E, Ahmadirad H, Riahi P, Mirmiran P, Daneshpour MS, Azizi F. Teymoori F, et al. BMC Public Health. 2024 Oct 16;24(1):2854. doi: 10.1186/s12889-024-20362-7. BMC Public Health. 2024. PMID: 39415141 Free PMC article.
References
- Azizi F, Rahmani M, Emami H, Mirmiran P, Hajipour R, Madjid M, Ghanbili J, Ghanbarian A, Mehrabi Y, Saadat N, Salehi P, Mortazavi N, Heydarian P, Sarbazi N, Allahverdian S, Saadati N, Ainy E, Moeini S. Cardiovascular risk factors in an Iranian urban population: Tehran Lipid and Glucose Study (Phase 1) Soz Praventivmed. 2002;47:408–426. - PubMed
- Sarraf-Zadegan N, Boshtam M, Malekafzali H, Bashardoost N, Sayed-Tabatabaei FA, Rafiei M, Khalili A, Mostafavi S, Khami M, Hassanvand R. Secular trends in cardiovascular mortality in Iran, with special reference to Isfahan. Acta Cardiol. 1999;54:327–33. - PubMed
- Hadaegh F, Harati H, Ghanbarian A, Azizi F. Prevalence of coronary heart disease among Tehranian adults: Tehran Lipid and Glucose Study. East Mediterr Health J. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous